Adial Pharmaceuticals (ADIL)
(Delayed Data from NSDQ)
$0.35 USD
0.00 (-0.43%)
Updated Sep 19, 2025 04:00 PM ET
After-Market: $0.35 0.00 (0.00%) 7:58 PM ET
2-Buy of 5 2
F Value B Growth A Momentum C VGM
Fundamental Charts
About Cash from Investing (TTM)
The company's trailing twelve month (TTM) Cash from Investing is the sum of the company's past 12 months cash position resulting from any gains or losses from investments in the financial markets, operating activities, and changes resulting from amounts spent on investments in capital assets such as plant and equipment. When evaluating the Cash from Investing value, it is important to consider each of the various activities which contribute to the overall change in cash position. A company can have a negative cash flow from investing and have a positive cash from Cash from operations or financing.
ADIL 0.35 0.00(-0.43%)
Will ADIL be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for ADIL based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for ADIL
All You Need to Know About Adial Pharmaceuticals (ADIL) Rating Upgrade to Buy
Adial Pharmaceuticals (ADIL) Upgraded to Strong Buy: Here's Why
ADIL: What are Zacks experts saying now?
Zacks Private Portfolio Services
Adial Pharmaceuticals (ADIL) Upgraded to Buy: Here's What You Should Know
Other News for ADIL
Is ADIL ready to move lower? Non-ADX 1,2,3,4 Bearish shows up after slipping 0.43%
Is ADIL likely to continue higher? Stochastic Buy Signal shows up after rising 1.3%
Narrow Range Bar appears for ADIL after 0.0% move
MACD Bullish Signal Line Cross appears for ADIL after 0.86% move
Adial Pharmaceuticals Advances AD04 with FDA Support